Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Conditions
- Diffuse Large B Cell Lymphoma
- Burkitt Lymphoma
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
Interventions
- DRUG: BTK inhibitor+ Fludarabine-based chemotherapy + CAR-T-CD19 Cells
- DRUG: Fludarabine-based chemotherapy + CAR-T-CD19 Cells
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators